Mesoblast Limited

MESO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$14.47+2.12%

2026-08-03

Financials

Valuation Metrics

Mesoblast Limited's Market Cap is $1.87B. At end of 2025 it was $2.30B. Ranked #2100 of 3,112 in US market (top 67%), #812 of 1,445 on NASDAQ (top 56%), #144 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 54%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.87B	US#2,100/3,112 Sec#144/269
Revenue	$65M	US#2,842/3,112 Sec#148/269
Net Income	$-94M	US—/3,112 Sec—/269
Total Assets	$782M	US#2,552/3,112 Sec#110/269
Net Assets	$575M	US#2,152/3,112 Sec#99/269
Value
P/B	3.26x	US#1,769/3,112 Sec#96/269
P/S	28.61x	US#2,848/3,112 Sec#157/269
FCF Yield	-3.14%	US—/3,112 Sec—/269
Profitability
ROE	-16.42%	US#2,483/3,112 Sec#96/269
ROA	-12.06%	US#2,681/3,112 Sec#107/269
Op. Margin	-223.08%	US#2,866/3,112 Sec#143/269
Revenue Growth	1526.81%	US#23/3,112 Sec#11/269
Financial Health
Debt Ratio	36.13%	US#409/3,112 Sec#116/269
Total Debt	$135M	US#2,309/3,112 Sec#107/269
FCF	$-59M	US#2,489/3,112 Sec#119/269
Cash	$130M	US#2,041/3,112 Sec#158/269
Current Ratio	1.58x	US#1,586/3,112 Sec#241/269
Performance
1Y Return	-4.61%	US#2,257/3,112 Sec#206/269
1M Return	0.63%	US#1,555/3,112 Sec#66/269
From 52W High	-32.70%	US#2,278/3,112 Sec#173/269
1Y MDD	-37.07%	US#1,810/3,112 Sec#129/269
Trading
Volume	227,147 shares	US#2,582/3,112 Sec#247/269
Trading Value	$3M	US#2,798/3,112 Sec#231/269
Per Share
EPS	$-0.65	US—/3,112 Sec—/269
BPS	$4.76	US#2,248/3,112 Sec#135/269